VANGUARD FIDUCIARY TRUST CO
BankPosition in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 933478
MALVERN, PA
Position in AMLX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$8,147,512
New position
Shares Held
586,152
first reported quarter
Ownership
0.527%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VANGUARD FIDUCIARY TRUST CO holds $1,022,608,473 across 55 Drug Manufacturers - Specialty & Generic names. AMLX ranks #18 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,395,410 | $283,161,416 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
267,978 | $158,905,594 | |
| 3 | VTRS |
Viatris Inc
|
6,485,909 | $87,624,630 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
634,340 | $83,567,951 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,085,266 | $73,830,415 | |
| 6 | ALKS |
Alkermes plc.
|
1,129,236 | $39,929,784 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
458,977 | $34,813,405 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
1,449,385 | $30,089,232 |
All Filings in AMLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,147,512 | 586,152 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||